In this study, we demonstrated that LNMAT1 epigenetically upregulated CCL2 expression in bladder cancer cells by interacting with hnRNPL to promote H3K4me3 of the CCL2 promoter. The gene discussed is DUXAP9; the disease is urinary bladder cancer.